From initial market assessment to sustained commercial operations, we manage every phase of international pharmaceutical market entry.
A structured, repeatable methodology refined across 35+ product registrations in 18+ markets.
Market sizing, competitive landscape, regulatory pathway mapping, and commercial feasibility analysis.
Dossier preparation, authority submission, GMP documentation, and regulatory approval management.
Distribution partner selection, import licensing, pricing strategy, and commercial launch planning.
Government tender participation, formulary inclusion, demand generation, and post-market surveillance.
Before entering any market, we build a comprehensive intelligence picture that informs every subsequent decision.
Demand modeling based on epidemiological data, current treatment protocols, healthcare spending, and competitive product availability.
Analysis of incumbent products, pricing structures, distribution channels, and market share dynamics.
Optimal pricing strategy based on local purchasing power, reference pricing systems, and reimbursement mechanisms.
Quantitative analysis of market opportunity, competitive dynamics, and pricing landscapes.
End-to-end registration management with direct authority engagement across all target markets.
Our regulatory team manages the complete registration lifecycle, from dossier preparation to authority approval.
Complete Common Technical Document compilation including quality, preclinical, and clinical modules tailored to each authority's requirements.
Direct engagement with COFEPRIS, ANVISA, NAFDAC, SAHPRA, and other national health authorities through our local regulatory partners.
We identify and leverage fast-track registration pathways for products with existing FDA, EMA, or WHO prequalification approvals.
We manage the operational complexity of getting pharmaceutical products from manufacturer to patient, across borders and regulatory jurisdictions.
Import licensing, customs documentation, controlled substance permits, and duty optimization for pharmaceutical products.
Temperature-controlled logistics from origin to destination, including GDP-compliant warehousing and last-mile delivery coordination.
Partnerships with tier-1 pharmaceutical distributors in each market for hospital, pharmacy, and wholesale channel coverage.
GDP-compliant logistics infrastructure spanning manufacturer to patient across 18+ markets.
Long-term commercial relationships structured for sustainable growth and mutual value creation.
We structure and manage the commercial relationships that underpin sustainable market presence.
Negotiation and management of territory-specific exclusive distribution rights between manufacturers and local partners.
Government tender identification, bid preparation, pricing strategy, and submission management for institutional sales.
Post-market surveillance, adverse event reporting, periodic safety update reports, and regulatory compliance monitoring.
We concentrate on therapeutic areas where market gaps are most pronounced in our target regions.
Injectable anesthetics, muscle relaxants, reversal agents, and ICU medications.
Cytotoxic agents, targeted therapies, and supportive care products for cancer treatment.
Analgesics, opioid reversal agents, and non-opioid pain management alternatives.
Antibiotics, antifungals, antivirals, and antimalarial products for infectious disease management.
Overdose reversal, antidotes, emergency cardiac medications, and trauma care products.
IV fluids, electrolytes, nutritional products, and essential hospital-use medicines.
We offer confidential, no-obligation initial assessments for manufacturers exploring Latin American or African market entry. Contact us to discuss your product and target markets.
Request Assessment